Several preclinical and clinical data reported that an increase in ADMA infusion alone causes a marked reduction in serum BDNF levels leading to behavioral changes and depression of CKD in 11 hemodialyzed patients as well as in nephrectomized rats. Here, BDNF is linked to chronic kidney disease.